HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$0.52
Day range
$0.50 - $0.58
Year range
$0.42 - $356.00
Market cap
3.16M USD
Avg Volume
320.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.06M | -26.14% |
Net income | -4.09M | 20.38% |
Net profit margin | — | — |
Earnings per share | -19.01 | 93.91% |
EBITDA | -4.03M | 26.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.77M | -44.40% |
Total assets | 5.17M | -31.87% |
Total liabilities | 3.53M | -18.83% |
Total equity | 1.64M | — |
Shares outstanding | 5.81M | — |
Price to book | 0.20 | — |
Return on assets | -131.81% | — |
Return on capital | -284.81% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -4.09M | 20.38% |
Cash from operations | -5.66M | -40.89% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 978.15K | 333.16% |
Net change in cash | -4.69M | -22.58% |
Free cash flow | -4.00M | -68.32% |
About
Founded
2016
Headquarters
Website
Employees
10